Related Experiment Video
Updated: Dec 15, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1
Aidan McGlinchey1, Tim Sinioja2, Santosh Lamichhane3
1School of Medical Sciences, Örebro University, 702 81 Örebro, Sweden.
Insights
High perfluoroalkyl substances (PFAS) exposure during pregnancy may increase type 1 diabetes (T1D) risk in children by altering lipid profiles and immune markers. This finding links environmental pollutants to T1D pathogenesis.
Area of Science:
- Environmental Health
- Immunology
- Endocrinology
Background:
- Type 1 Diabetes (T1D) incidence stabilization in Finland correlates with stricter Perfluoroalkyl Substances (PFAS) regulation.
- PFAS are persistent environmental pollutants with potential endocrine-disrupting effects.
- Understanding the prenatal impact of PFAS on T1D risk is crucial for public health.
Purpose of the Study:
- To quantify PFAS levels in pregnant women and assess their association with lipid and immune markers related to T1D risk in offspring.
- To investigate the role of PFAS in T1D pathogenesis using a mouse model.
Main Methods:
- Analysis of PFAS concentrations in maternal and cord serum from a mother-infant cohort (264 dyads).
- Measurement of cord serum phospholipids and islet autoantibodies.
- Experimental exposure of non-obese diabetic mice to PFAS and/or organic pollutants, followed by lipid profiling and histological analysis of pancreatic islets.
Main Results:
- High prenatal PFAS exposure was linked to reduced cord serum phospholipids and increased progression to T1D-associated islet autoantibodies in children.
- The association between PFAS and lipid changes was more pronounced in infants with high human leukocyte antigen (HLA)-conferred T1D risk.
- PFAS exposure in mice induced a similar decrease in phospholipids, elevated lithocholic acid, and accelerated insulitis (pancreatic inflammation).
Conclusions:
- Prenatal exposure to Perfluoroalkyl Substances (PFAS) is associated with altered lipid metabolism and immune responses that may contribute to Type 1 Diabetes (T1D) risk in offspring.
- PFAS may play a role in the pathogenesis of T1D, potentially through mechanisms involving lipid dysregulation and inflammation.
- These findings highlight the importance of environmental monitoring and regulation of PFAS to protect children's health.
Abstract:
In the last decade, increasing incidence of type 1 diabetes (T1D) stabilized in Finland, a phenomenon that coincides with tighter regulation of perfluoroalkyl substances (PFAS). Here, we quantified PFAS to examine their effects, during pregnancy, on lipid and immune-related markers of T1D risk in children. In a mother-infant cohort (264 dyads), high PFAS exposure during pregnancy associated with decreased cord serum phospholipids and progression to T1D-associated islet autoantibodies in the offspring. This PFAS-lipid association appears exacerbated by increased human leukocyte antigen-conferred risk of T1D in infants. Exposure to a single PFAS compound or a mixture of organic pollutants in non-obese diabetic mice resulted in a lipid profile characterized by a similar decrease in phospholipids, a marked increase of lithocholic acid, and accelerated insulitis. Our findings suggest that PFAS exposure during pregnancy contributes to risk and pathogenesis of T1D in offspring.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

